Different Surgical Modalities in the Treatment of Periodontitis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the most efficient treatment approach (two surgical and one non-surgical) in the treatment of moderate to severe chronic periodontitis, with regard to healing and resolution of disease, patient reported outcomes and cost effectiveness.
| Condition | Intervention | Phase |
|---|---|---|
|
Chronic Periodontitis |
Procedure: Non-surgical Subgingival Debridement (SD) Procedure: Simplified Papilla Preservation Flap Procedure: Resective Periodontal Flap with Osseous Recontouring (RPFO) |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | The Efficacy of Different Surgical Modalities in the Treatment of Periodontitis. A Single-Centre Randomised Controlled Trial |
- Change from Baseline in Periodontal Probing Depths (PPD) [ Time Frame: 3, 6 and 12 months ] [ Designated as safety issue: No ]A clinical measure of resolution of disease
- Change from Baseline of EuroQol-5D-3L and Condition Specific Oral Impacts on Daily Performance Questionnaire [ Time Frame: 3, 6, 9 and 12 months ] [ Designated as safety issue: No ]To assess impact on quality of life.
- Incremental cost per quality-adjusted life year gained [ Time Frame: 3, 6, 9 and 12 months ] [ Designated as safety issue: No ]To determine cost-effectiveness from an NHS perspective
- Clinical attachment level (CAL) change [ Time Frame: 3, 6 and 12 months ] [ Designated as safety issue: No ]
- Radiographic bone change [ Time Frame: 12 months ] [ Designated as safety issue: No ]As determined from standardized peri-apical radiographs
- Change in subgingival microbiota [ Time Frame: 3, 6 and 12 months ] [ Designated as safety issue: No ]Assessed via pooled samples and analyzed via Q-PCR
| Estimated Enrollment: | 117 |
| Study Start Date: | January 2013 |
| Estimated Study Completion Date: | December 2016 |
| Estimated Primary Completion Date: | December 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Non-surgical subgingival debridement |
Procedure: Non-surgical Subgingival Debridement (SD)
SD is a conservative non-surgical procedure aimed at reducing dental plaque and calculus from the tooth root usually under local anaesthesia.
|
| Active Comparator: Simplified Papilla Preservation Flap |
Procedure: Simplified Papilla Preservation Flap
The simplified papilla preservation flap is a novel conservative surgical procedure aimed at the preservation of the tissues between the teeth. It has been shown to significantly reduce pocket depth and has faster re-vascularisation of the flap, when compared with other procedures.
|
| Active Comparator: Resective Flap with Osseous Recontouring |
Procedure: Resective Periodontal Flap with Osseous Recontouring (RPFO)
RPFO is a surgical procedure that involves the resection of soft and hard tissue to obtain optimum tissue architecture and pocket reduction or elimination.
|
Detailed Description:
Periodontal diseases (PD) are highly prevalent chronic diseases, and may be associated with loss of gum and bone tissue surrounding the tooth. Among adults (with 2 or more teeth remaining) in England, 54% experienced gum bleeding and 45% had periodontal (gum) disease of which 9% was severe. Bacterial in origin, the high prevalence of PD, together with increased retention of teeth at older ages, has considerable implications for the population's future treatment needs and the associated costs to the health system. It is therefore important to ensure interventions delivered are those proven to be most efficient and cost effective. The investigators study question will therefore be, "In an adult population with moderate to severe chronic periodontitis, how will 3 different treatment approaches; simplified papilla preservation flap (SPPF), resective periodontal flap with osseous recontouring (RPFO) and subgingival debridement (SD), differ in regard to healing and resolution of disease, patient reported outcomes and cost effectiveness?" The aim of this study is to find the most efficient way to treat chronic periodontitis, through a randomised controlled trial of 3 established forms of treatment.
Research will be carried out at the Eastman Dental Institute and Hospital, specifically in the Eastman Clinical Investigation Centre (ECIC), a dedicated clinical research centre. A total of 117 participants will be recruited in order to provide the necessary power to discriminate between the 3 treatment approaches. Eligible patients, who fit the inclusion criteria, will be drawn from hospital referrals and once informed consent is gained, will be randomised to one of the 3 approaches. Two surgical approaches (SPPF, RPFO) will be compared with a non-surgical (SD) approach, and followed up over a 12 month period. Among other things, the investigators will compare clinical parameters of wound healing (including bacterial changes), patient's quality of life and cost-effectiveness.
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Systemically healthy males and females ≥ 30 years of age.
- Non-smokers or smokers (≤10 cigarettes per day).
- Volunteers must be willing to read, and sign a copy of the Informed Consent Form after reading the Patient Information Leaflet and after the nature of the study has been fully explained.
- Present at least two interdental areas with pockets ≥6mm (PPD), bleeding on probing (BOP), and attachment loss ≥6mm in at least 2 posterior sextants of their mouth.
- Have completed a course of non-surgical periodontal therapy within 2 years prior to study commencement and have had maintenance subgingival debridement within 6 months prior to assessment for eligibility.
Exclusion Criteria:
- Medical history that includes uncontrolled diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases, e.g. cardiovascular disease or AIDS.
- History of rheumatic fever, heart murmur, mitral valve prolapse, artificial heart valve or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.
- Antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
- History of alcohol or drug abuse.
- Self reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing which can affect interpretation of study results).
- Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.
Contacts and Locations| Contact: Nikolaos Donos, DDS, MS, PhD | +44(0)2034561075 | n.donos@ucl.ac.uk |
| Contact: Natalie Leow, BDS, MDSc | +44(0)2034561171 | n.leow@ucl.ac.uk |
| United Kingdom | |
| Eastman Clinical Investigation Centre | Recruiting |
| London, United Kingdom, WC1X 8LD | |
| Contact: Natalie M Leow, BDS, MDSc +44(0)2034561171 n.leow@ucl.ac.uk | |
| Principal Investigator: Nikolaos Donos, DDS, MS, PhD | |
| Principal Investigator: Nikolaos Mardas, DDS, MS, PhD | |
| Principal Investigator: Natalie M Leow, BDS, MDSc | |
| Sub-Investigator: Ian Needleman, BDS,MSc,PhD | |
| Sub-Investigator: Nikolaos Gkranias, DDS,MClinDen | |
| Sub-Investigator: Aviva Petrie, BSc,MSc,CSta | |
| Sub-Investigator: Georgios Tsakos, Dip,MSc,PhD | |
| Sub-Investigator: Jeanie Suvan, DipDH,MSc | |
| Sub-Investigator: Stephen Morris, MSc, PhD | |
| Sub-Investigator: Martin Utley, BSc,PhD | |
| Sub-Investigator: Francesco D'Aiuto, DMD,PhD | |
| Sub-Investigator: Xanthippi Dereka, DDS, PhD | |
| Sub-Investigator: David Spratt, PhD | |
| Sub-Investigator: Roberto Rotundo, DDS | |
| Sub-Investigator: Ulpee Darbar, BDS, MSc | |
| Principal Investigator: | Nikolaos Donos, DDS, MS, PhD | UCL Eastman Dental Institute |
| Study Director: | Nikolaos Mardas, DDS, MS, PhD | UCL Eastman Dental Institute |
| Study Chair: | Natalie M Leow, BDS, MDSc | UCL Eastman Dental Institute |
More Information
No publications provided
| Responsible Party: | University College, London |
| ClinicalTrials.gov Identifier: | NCT01642641 History of Changes |
| Other Study ID Numbers: | P-07-34 |
| Study First Received: | July 11, 2012 |
| Last Updated: | February 14, 2013 |
| Health Authority: | United Kingdom: National Health Service |
Additional relevant MeSH terms:
|
Periodontitis Chronic Periodontitis Periodontal Diseases Mouth Diseases Stomatognathic Diseases |
ClinicalTrials.gov processed this record on May 21, 2013